HWI pharma servcies GmbH offers innovative technolgies and services for Pharma and Biotech-industries, particularly for active ingredients and medicinal products with small and large molecules.
Our end-to-end service concept covers all phases along the pharmaceutical value chain. Our service portfolio ranges from formulation development, analytical development and quality control, manufacturing of clinical batches and smaller market batches to pre-clinical development, pharmacovigilance and GxP services.

At Ruelzheim site, the focus is on development and validation of analytical methods, trace analysis, troubleshooting, quality control and stability testing. The laboratories are GMP- and FDA-certified and hold a manufacturing licence for the release of clinical and market batches. We have our own GVP-compliant pharmacovigilance system and offer extensive support regarding pharmacovigilance and GxP services.

Frankfurt site specialises in the development and small batch production of liquid and semi-solid medicinal products for external, nasal and parenteral use. Active ingredients can be handled up to OEB class 5.

At Appenweier site, the focus is on development of oral solid medicinal products, characterisation of active substances and manufacturing of clinical trial samples and small-scale batches.

HWI is a family-owned, independent service partner in the pharma and biotech sector. We stands for quality, flexibility, competence and reliability.

Media

---